Geller A I
Department of Neurology, Massachusetts General Hospital, Boston 02114.
J Neurosci Methods. 1991 Jan;36(1):91-103. doi: 10.1016/0165-0270(91)90142-m.
Among the potential uses of defective herpes simplex virus (HSV-1) vectors are to study neuronal physiology, neuronal gene regulation, and to perform gene therapy of neuronal diseases. The prototype HSV-1 vector, pHSVlac, stably expresses Escherichia coli beta-galactosidase from the HSV-1 immediate early (IE) 4/5 promoter in cultured rat peripheral and CNS neurons, and in neurons in the adult rat brain. The LacZ gene and the IE 4/5 promoter in pHSVlac can be replaced with genes which affect neuronal physiology or cellular promoters, respectively. A system is required to characterize these HSV-1 vectors; cultured neurons, a mixture of different kinds of neurons and glia, cannot be used. In contrast, neural cell lines represent a homogenous population of neural cells available in virtually unlimited quantities. A system, using neural cell lines, to characterize HSV-1 vectors carrying other genes or promoters is now reported: First, 4 assays are described to detect HSV-1 vector DNA, RNA transcribed from the vector, and to quantitate beta-galactosidase expression. Second, 8 cell lines derived from rodents, primates, and humans were infected with pHSVlac virus and shown to express beta-galactosidase. The cell lines tested included adrenergic and cholinergic mouse neuroblastoma cells, rat pheochromocytoma cells, rodent pituicytes, and human neuroblastoma cells. Infection of these cell lines should prove useful for characterizing HSV-1 vectors with molecular and biochemical assays. Third, differentiated rat pheochromocytoma and mouse neuroblastoma cells, which resemble neurons, were infected with pHSVlac virus and shown to stably express beta-galactosidase. Infection of these cells should be useful for determining the effect of various HSV-1 vectors on neuronal physiology. Thus, HSV-1 vectors containing various genes or promoters can be characterized using the system described in this study.
缺陷型单纯疱疹病毒(HSV-1)载体的潜在用途包括研究神经元生理学、神经元基因调控以及对神经元疾病进行基因治疗。原型HSV-1载体pHSVlac在培养的大鼠外周和中枢神经系统神经元以及成年大鼠脑神经元中,从HSV-1立即早期(IE)4/5启动子稳定表达大肠杆菌β-半乳糖苷酶。pHSVlac中的LacZ基因和IE 4/5启动子可分别被影响神经元生理学的基因或细胞启动子取代。需要一个系统来表征这些HSV-1载体;不能使用培养的神经元,即不同种类神经元和神经胶质细胞的混合物。相比之下,神经细胞系代表了数量几乎无限的同质神经细胞群体。现在报道了一种使用神经细胞系来表征携带其他基因或启动子的HSV-1载体的系统:首先,描述了4种检测方法,用于检测HSV-1载体DNA、从载体转录的RNA以及定量β-半乳糖苷酶表达。其次,用pHSVlac病毒感染了8种源自啮齿动物、灵长类动物和人类的细胞系,结果显示它们表达β-半乳糖苷酶。所测试的细胞系包括肾上腺素能和胆碱能小鼠神经母细胞瘤细胞、大鼠嗜铬细胞瘤细胞、啮齿动物垂体细胞和人类神经母细胞瘤细胞。用分子和生化检测方法感染这些细胞系应该有助于表征HSV-1载体。第三,用pHSVlac病毒感染了类似于神经元的分化大鼠嗜铬细胞瘤和小鼠神经母细胞瘤细胞,结果显示它们稳定表达β-半乳糖苷酶。感染这些细胞应该有助于确定各种HSV-1载体对神经元生理学的影响。因此,使用本研究中描述的系统可以表征含有各种基因或启动子的HSV-1载体。